Study shows significant increase in antibiotic use across the world

July 11, 2014 by Wendy Plump, Princeton University

Global use of antibiotics is surging, according to Princeton University researchers who have conducted a broad assessment of antibiotic consumption around the world.

The study, "Global Trends in Antibiotic Consumption, 2000-2010," found that worldwide antibiotic use has risen a staggering 36 percent over those 10 years, with five countries—Brazil, Russia, India, China and South Africa (BRICS)—responsible for more than three-quarters of that surge, according to study authors Thomas Van Boeckel, Simon Levin, Bryan Grenfell, Ramanan Laxminarayan and Quentin Caudron of Princeton.

Among the 16 groups of antibiotics studied, cephalosporins, broad-spectrum penicillins and fluoroquinolones accounted for more than half of that increase, with consumption rising 55 percent from 2000 to 2010.

The study quantifies the growing alarm surrounding antibiotic-resistant pathogens, and a loss of efficacy among antibiotics used to combat the most common illnesses. In addition, the report highlights an increasing resistance to carbapenems and polymixins, two classes of drugs long considered "last resort" antibiotics for illnesses without any other known treatment.

Overall, the study reviewed patterns, seasonality and frequency of use of antibiotics in 71 countries. The findings of the report are featured July 10 in the journal The Lancet Infectious Diseases.

There was some good news. The data underscore the welcome evidence that more global citizens are able to access and purchase antibiotics. But that use is not being effectively monitored by health officials, from doctors to hospital workers to clinicians, noted the researchers. Consequently, antibiotic use is both rampant and less targeted.

That reality is driving antibiotic resistance at an unprecedented rate.

"We have to remember that before we had antibiotics, it was pretty easy to die of a ," said Laxminarayan, a research scholar with the Princeton Environmental Institute. "And we're choosing to go back into a world where you won't necessarily get better from a bacterial infection. It's not happening at a mass scale, but we're starting to see the beginning of when the antibiotics are not working as well."

The study found that India was the single-largest consumer of antibiotics in the world in 2010, followed by China and the United States.

The study also found that antibiotic consumption has flattened in the United States, compared with the five BRICS countries. But U.S. citizens per capita still account for far more antibiotic consumption than any other population, with a rate of more than twice that of India.

"This paper breaks new ground with the comparative antibiotic consumption data by country of the first decade of the 21st century," said Professor Dame Sally Davies, chief medical officer for England and chief scientific adviser for the Department of Health, London. "There is a direct relationship between consumption and development of antibiotic resistance, so the data is key for us all developing 'National Action Plans Against Antimicrobial Resistance' as set out in the World Health Assembly Resolution in May."

The study noted that antibiotic use tended to peak at different times of the year, corresponding in almost every case with the onset of the flu season. In the northern hemisphere, for example, consumption peaked between January and March, while in the southern hemisphere it peaked between July and November. One notable exception was India, for which usage peaked between July and September, correlating with the end of the monsoon season.

"This is a problem at the scale of climate change in terms of urgency," said Laxminarayan. "But we don't have anything close to the architecture of science to look at this problem, to look at solutions, to look at where the problem is the worst."

Laxminarayan and Levin received a grant from the University's Grand Challenges Program to study the problem of antibiotic resistance as part of general work on "common property" problems, those areas in which individuals or small groups make decisions—such as on how they use antibiotics—that have national or global consequences.

The research was conducted by Van Boeckel, postdoctoral research fellow; Caudron, postdoctoral researcher; Grenfell, the Kathryn Briger and Sarah Fenton Professor of Ecology and Evolutionary Biology and Public Affairs at the Woodrow Wilson School; Levin, the George M. Moffett Professor of Biology and professor of ecology and evolutionary biology; and Laxminarayan. In addition, two scholars from the Center for Disease Dynamics, Economics & Policy in Washington, D.C., were involved. The data supporting the study results were drawn from IMS Health, a private company that collects sales data on global drug pharmaceuticals.

The research group frames the issue of as more than a global health concern. Because the study found a strong correlation between seasonality and antibiotic consumption—for example during flu seasons, for which antibiotic use is "inappropriate"—Levin sees the issue as having a strong environmental component, as well.

"Keep in mind that we're not the primary organism on this planet. It's really bacteria," Levin said. "And we in no way understand bacteria to the degree that we should. Instead, we're just dumping antibiotics on them, and then we think we're winning the war on bugs. There is no winning the war on bugs.

"We're modifying that bacteria, where we dump antibiotics into agriculture, we put them on fruit trees, we prescribe them in outpatient clinics—we have been running this massive experiment for about 50 years without really knowing what it's doing. What are the consequences of that?"

Programs promoting "rational use" of antibiotics should be a national and global priority, said the report's authors. That process has to begin with the BRICS countries, which are experiencing the highest rates of increase in antibiotic consumption.

While the report did not include specific recommendations, Laxminarayan suggested that a universally adopted algorithm for prescribing might help assure their appropriate use. Such an algorithm would not require a doctor's authorization, he said. It would merely require a practitioner committed to observing it.

Explore further: Global effort is needed to keep antibiotics working

More information: Thomas P Van Boeckel, Sumanth Gandra, Ashvin Ashok, Quentin Caudron, Bryan T Grenfell, Simon A Levin, Ramanan Laxminarayan, "Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data," The Lancet Infectious Diseases, Available online 9 July 2014, ISSN 1473-3099, DOI: 10.1016/S1473-3099(14)70780-7.

Related Stories

Global effort is needed to keep antibiotics working

November 19, 2013
A global approach is needed to address the unfolding burden of antibiotic resistance, say the authors of a new report, published this week in Lancet Infectious Diseases. The report coincides with the European Antibiotic Awareness ...

High doses of antibiotics may have the potential to promote increased cross-resistance

June 24, 2014
Antibiotic resistance has become an increasing public health concern, with MRSA infections and last lines of antibiotic drug treatments having to be increasingly deployed in hospitals and clinics.

Study examines role of seasonal prescribing changes in antibiotic resistance

July 2, 2012
A new study published in Clinical Infectious Diseases and available online shows how seasonal changes in outpatient antibiotic use – retail sales of antibiotics typically get a boost during the winter – can significantly ...

Global efforts needed to curb antibiotic resistance

November 18, 2013
(HealthDay)—Global efforts are needed to curb antibiotic resistance, according to a report published online Nov. 16 in The Lancet Infectious Diseases.

CDC addresses burden, threat of antibiotic resistance

January 6, 2014
(HealthDay)—The burden and threats posed by antibiotic resistance infections are discussed in a report published by the U.S. Centers for Disease Control and Prevention.

Data on antibiotic use in non-EU countries should stimulate development of action plans

March 19, 2014
A new study, published in The Lancet Infectious Diseases journal, provides the first ever reliable data on antibiotic use in non-European Union (EU) southern and eastern European countries and newly independent states.

Recommended for you

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.